HHM Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Sell
31
-37
-54% -$13.7K ﹤0.01% 607
2026
Q1
$19.9K Buy
68
+37
+119% +$12.2K ﹤0.01% 516
2025
Q4
$10.9K Hold
31
﹤0.01% 603
2025
Q3
$10K Hold
31
﹤0.01% 637
2025
Q2
$12.1K Hold
31
﹤0.01% 583
2025
Q1
$13.5K Hold
31
﹤0.01% 558
2024
Q4
$11.4K Hold
31
﹤0.01% 570
2024
Q3
$16.1K Sell
31
-2
-6% -$1.07K ﹤0.01% 500
2024
Q2
$17.9K Buy
33
+2
+6% +$1.06K ﹤0.01% 470
2024
Q1
$16.1K Sell
31
-15
-33% -$7.46K ﹤0.01% 451
2023
Q4
$21.7K Hold
46
﹤0.01% 399
2023
Q3
$20K Hold
46
﹤0.01% 401
2023
Q2
$20.4K Hold
46
﹤0.01% 417
2023
Q1
$21.2K Buy
+46
New +$21.9K ﹤0.01% 411
2022
Q3
Sell
-20
Closed -$10K 683
2022
Q2
$10K Hold
20
﹤0.01% 532
2022
Q1
$10K Hold
20
﹤0.01% 534
2021
Q4
$9K Hold
20
﹤0.01% 520
2021
Q3
$7K Hold
20
﹤0.01% 520
2021
Q2
$8K Hold
20
﹤0.01% 488
2021
Q1
$7K Hold
20
﹤0.01% 472
2020
Q4
$6K Hold
20
﹤0.01% 449
2020
Q3
$5K Hold
20
﹤0.01% 428
2020
Q2
$5K Hold
20
﹤0.01% 408
2020
Q1
$5K Buy
+20
New +$5.45K ﹤0.01% 387

Other funds holding ELV

HHM Wealth Advisors's ELV Position: Q2 2026 in Review

HHM Wealth Advisors reduced its Elevance Health (ELV) stake by 54% in Q2 2026, selling an estimated $13.7K and leaving 31 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #607.

HHM Wealth Advisors first reported a position in ELV in Q1 2020 and has held it in 24 quarters since. The position peaked at $21.7K in Q4 2023. 466 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • HHM Wealth Advisors held 31 shares of Elevance Health worth $12K as of Q2 2026.
  • HHM Wealth Advisors sold 37 Elevance Health shares in Q2 2026, an estimated $13.7K.
  • Elevance Health made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #607 holding.
  • HHM Wealth Advisors first reported a position in Elevance Health in Q1 2020 and has held it in 24 quarters since.
  • HHM Wealth Advisors's Elevance Health position peaked at $21.7K in Q4 2023.
  • 466 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.